Apyx Medical Corp. (APYX) Tops Q3 EPS by 5c

Apyx Medical Corp. (NASDAQ: APYX) reported Q3 EPS of ($0.11), $0.05 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $7 million versus the consensus estimate of $5.68 million.

For earnings history and earnings-related data on Apyx Medical Corp. (APYX) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Goldman Sachs Assumes Klaviyo Inc (KVYO) at Buy
• FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance